Balyasny Asset Management
KDNY

Balyasny Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Balyasny Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$23.3M Buy
2023
Q1 		– Sell
2022
Q4 		$2.36M Sell
2022
Q3 		$5.51M Buy
2018
Q4 		– Sell
2018
Q3 		$595K Buy
2018
Q2 		$90K Buy
2017
Q2 		– Sell
2017
Q1 		$845K Buy